Literature DB >> 10623635

Increased carbon monoxide in exhaled air of critically ill patients.

M Scharte1, H G Bone, H Van Aken, J Meyer.   

Abstract

Heme oxygenase produces carbon monoxide (CO) during breakdown of heme molecules primarily in liver and spleen. Recent data suggest that CO is also produced in the lungs. CO is excreted by exhalation via the lungs. A number of inflammatory agents induce the expression of heme oxygenase, possibly leading to increased CO production. To investigate whether critical illness results in increased CO production we measured the CO concentration in exhaled air in 30 critically ill patients and in healthy controls (n = 6). Critically ill patients showed a significantly higher CO concentration in exhaled air (median 2.4 ppm, 95% CI 1.0-7.0 ppm vs median 1.55 ppm, 95% CI 1.2-1.7 ppm, P = 0.01) as well as total CO production (median 20 ml/min, 95% CI 8 to 90 ml/min vs median 13.5 ml/min, 95% CI 11 to 19 ml/min, P = 0.026) compared to healthy controls. No correlation was found between CO concentration in exhaled air and carboxyhemoglobin concentration in arterial and central venous blood (P > 0.05). The increase of CO concentration in exhaled air in critical illness suggests an induction of inducible heme oxygenase (HO-1) and might reflect the severity of illness. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623635     DOI: 10.1006/bbrc.1999.1936

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

2.  Exhaled carbon monoxide and risk of metabolic syndrome and cardiovascular disease in the community.

Authors:  Susan Cheng; Asya Lyass; Joseph M Massaro; George T O'Connor; John F Keaney; Ramachandran S Vasan
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

3.  Elevated carboxyhemoglobin associated with sodium nitroprusside treatment.

Authors:  Jesús López-Herce; Raúl Borrego; Amaya Bustinza; Angel Carrillo
Journal:  Intensive Care Med       Date:  2005-07-22       Impact factor: 17.440

4.  Changes in arterial oxygen tension correlate with changes in end-expiratory carbon monoxide level.

Authors:  Patrick Schober; Melanie Kalmanowicz; Lothar A Schwarte; Joerg Weimann; Stephan A Loer
Journal:  J Clin Monit Comput       Date:  2007-02-15       Impact factor: 2.502

Review 5.  Carbon monoxide in exhaled breath testing and therapeutics.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  J Breath Res       Date:  2013-02-27       Impact factor: 3.262

6.  Effects of inspiratory oxygen concentration on endtidal carbon monoxide concentration.

Authors:  Patrick Schober; Melanie Kalmanowicz; Stephan A Loer
Journal:  J Clin Monit Comput       Date:  2006-03-17       Impact factor: 2.502

7.  ECMO and endogenous carboxyhemoglobin formation.

Authors:  Ravi S Tripathi; Thomas J Papadimos
Journal:  Int J Crit Illn Inj Sci       Date:  2011-07

Review 8.  Pathological Impact of the Interaction of NO and CO with Mitochondria in Critical Care Diseases.

Authors:  J Catharina Duvigneau; Andrey V Kozlov
Journal:  Front Med (Lausanne)       Date:  2017-12-22

9.  Effects of acute hypoventilation and hyperventilation on exhaled carbon monoxide measurement in healthy volunteers.

Authors:  Franco Cavaliere; Carmen Volpe; Riccardo Gargaruti; Andrea Poscia; Michele Di Donato; Giovanni Grieco; Umberto Moscato
Journal:  BMC Pulm Med       Date:  2009-12-23       Impact factor: 3.317

10.  Protective effects of carbon monoxide-releasing molecule-2 on the barrier function of intestinal epithelial cells.

Authors:  Xinwei Mu; Chen Pan; Shuyun Zheng; Yasir Alhamdi; Bingwei Sun; Qiankun Shi; Xiang Wang; Zhiwei Sun; Chenghock Toh; Guozheng Wang
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.